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Since the initial observations of the involvement of lymphocytes in the active suppression of 
immune processes,  a  variety of suppressor cells  and substances have  been associated  with 
regulation of the immune response to a number of antigens (1, 2). Not only has such suppressor 
activity been associated with humoral and cellular mediated responses,  but suppressor cells 
have also been implicated in various models of immunologic unresponsiveness (3,  4).  The 
suppressor cells shown to be present in mice rendered tolerant to human ),-globulin (HGG) t 
(5-8) have been characterized as lymphocytes bearing T-cell antigens (6, 9), including theta 
(6) and Ly-2 (10), and Ia antigens (10, 11), including I-J (12). Suppressor T  cells generated 
during the induction of specific tolerance to HGG can suppress HGG-specific T and B cells in 
vivo (9) and hapten-specific B cells in vitro when hapten-coupled HGG is present in the cultures 
(6, 11, 13). Additionally,  soluble suppressor substances have been associated with spleen cells of 
HGG-tolerant mice (14-17). Adherent cells have also been implicated in the suppression of the 
immune response to HGG (6-9). Although suppressor cell activity is well documented in the 
tolerance to HGG, it appears to be only transiently associated with the unresponsive state (6, 
8,  18). 
Presently,  it  is  unclear whether  suppressor  T  cells,  which  are  involved  in  the 
regulation of the induction and magnitude of immune responses, play a major role in 
the establishment and maintenance of tolerance to serum proteins resembling self- 
antigens. Delineation of the precise mechanisms of induction and maintenance of the 
immunologic unresponsive state  to  HGG  awaits  the  clarification  of  the  role  of 
suppressor cells in these processes. The observation that suppressor T  cells accompany 
the tolerant state  is not universal. Specific suppressor cells have not been found in 
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mice rendered tolerant to HGG as neonates (19), in tolerant mice given a second dose 
of tolerogenic  HGG  at  a  time  when  the original  suppressor cells  have disappeared 
(20),  or during parabiosis of normal mice with HGG-tolerant  mice (21).  Suppressor 
cells  have not been  universally  demonstrated  even  within adults of a  single  inbred 
strain of mice (22, 23).  In light of the past variability  in the induction of suppressor 
cells during the establishment of the HGG-tolerant  state, it is of interest that nearly 
all of the investigators reporting suppressor cell activity appear to have utilized HGG 
from either of two commercial sources. The studies presented here demonstrate that 
the source of antigen is crucial to the degree of suppressor cell activity stimulated  in 
tolerized mice and that this degree of suppression does not reflect the induction and 
maintenance of the tolerant state of these animals. These studies further emphasize 
the lack of an obligatory role of suppressor cells in these events. 
Materials and Methods 
Animals.  Male  A/J  mice  were  purchased  from  The  Jackson  Laboratory  (Bar  Harbor, 
Maine) at 4-5 wk of age. They were maintained on Wayne Lab Blox F6 (Allied Mills, Inc., 
Chicago, Ill.) and acidified water ad libitum. All mice were housed five to a cage. Mice ranging 
in age from 8 to 13 wk were used in these experiments. 
Antigens.  Cobn  Fraction II of human  plasma was obtained through  the courtesy of the 
American Red Cross (RC) National Fractionation Center with the partial support of National 
Institutes of Health grant HE 13881 HEM, lot RC-104, and it was also purchased from Miles 
(M)  Laboratories, Inc.  (Elkhart, Ind.), lot 41;  Sigma (S) Chemical Co.  (St. Louis, Mo.), lot 
46(2-0198;  and United States (US)  Biochemical Corp.  (Cleveland, Ohio), lot  10600.  Human 
plasma from a myeloma patient (Fit) expressing an IgG1 X-myeloma protein was obtained by 
plasmaphoresis through  the generosity of Dr.  Hans  Spiegelberg of this department. Normal 
plasma was  obtained  from  one  of us  (Doy)  by  defibrination with  glass beads.  The  Cohn 
fractions were dissolved in 0.01  M  potassium-phosphate buffer, pH 8.0,  before column chro- 
matography, whereas the normal and myeloma plasma were dialyzed at 4°C against 0.01 and 
0.005  M  phosphate buffers, respectively, to precipitate euglobulins from the samples before 
further  purification. A  nondialyzed sample of the normal  plasma was  precipitated in  20% 
ethanol at -6°C  (24),  lyophilized, and dissolved in 0.01  M  phosphate buffer before chroma- 
tography.  HGG  was  purified from  these materials by column  chromatography on  DEAE- 
cellulose in 0.01  M  phosphate buffer, pH 8.0, except in the case of the myeloma protein which 
was chromatographed in 0.005 M  phosphate buffer at pH 8.0. 
Induction of Tolerance.  Tolerogenic, deaggregated HGG (DHGG) was prepared by ultracen- 
trifugation of DEAE-purified HGG to remove aggregates by a modification (8) of the previously 
described method (25).  5 ml of HGG was centrifuged for 150 min at 4°C and 41,000 rpm in 
polyallomer tubes (model 326819)  in a  swinging bucket SW 50.1  rotor (both from Beckman 
Instruments, Inc., Palo Alto, Calif.). The upper quarter of the centrifuged solution was carefully 
removed and diluted to a  final concentration of 2.5  mg/ml in sterile, nonpyrogenic, 0.15  M 
NaC1  (McGaw  Laboratories,  Irvine,  Calif.).  Mice  received  1  ml  of  DHGG  i.p.  Protein 
concentration was determined by optical density of appropriate dilutions with an extinction 
coefficient  1~  of E~0nm. lem =  15. 
Immunizations.  Immunogenic,  heat-aggregated  HGG  (A-AHGG)  was  prepared  from  the 
DEAE-purified Cohn fractions ~ind from normal plasma as described previously (25),  using a 
modification of Gamble's method  (26).  Chromatographed  myeloma protein, which  did not 
aggregate upon heating (27), was aggregated with bis-diazotized benzidine (27). Benzidine was 
obtained from Calbiochem (San Diego, Calif.). Mice received a primary injection of 400 ~g of 
A-AHGG or bis-diazotized benzidine-aggregated HGG i.v. into a lateral caudal vein followed 
10 days later by a secondary injection of the same amount of antigen i.p. Those mice also given 
bacterial lipopolysaccharide (LPS) were injected i.v. 3 h after primary antigenic challenge with 
50  ~g  of a  phenol-extracted  preparation  from  Escherichia coil 0111:B4,  lot  614378  (Difco 
Laboratories, Detroit, Mich.), diluted in pyrogen-free, 0.15 M  sterile NaCl. 
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tution.  Mice placed in an aluminum chamber in a Gamma Cell  40 small animal irradiator 
(Atomic Energy of Canada, Ltd., Ottawa, Canada) received 900 R of whole body irradiation 
from a  cesium  137  source  emitting a  central  dose  of 109  R/min.  Reconstituted  recipients 
received 100 ttg of gentamicin (Schering-Pharmaceutical Corp., Kenilworth, N. J.) diluted in 
2.7% glucose in saline i.p. on the day of'irradiation and again 3 days later, and they were caged 
in groups of two to avoid early irradiation death, presumably due to bacterial infection. 
Adoptive Cell Transfer.  Cell transfers were accomplished as described  previously (28). Briefly, 
irradiated recipients were reconstituted i.v. with washed spleen cells, and they were immunized 
immediately and  again  10  days later.  5 days after the secondary challenge,  the  recipients' 
spleens were removed and individually assayed for plaque-forming cells (PFC). 
Hemolytic Plaque Assay.  PFC to HGG were assayed by a slide modification of the hemolytic 
plaque  assay (29). Cohn  fraction II HGG at  a  concentration  of 20  mg/ml was covalently 
coupled to goat erythrocytes (GRBC) (Colorado Serum Co., Denver, Colo.) using water-soluble 
carbodiimide  [1-ethyl-3-(3-dimethylaminopropyl) earbodiimide  hydrochloride]  from  Calbi- 
ochem (30). This HGG was previously absorbed against GRBC. Plaques were developed with 
guinea pig serum (Pel-Freez  Biologicals  Inc., Rogers,  Ark.)  as a source  of complement, and 
indirect plaques were amplified with rabbit anti-mouse IgG serum previously absorbed against 
HGG and GRBC. 
Statistical Methods.  Results  of the plaque assay are expressed  as the mean number of PFC 
per spleen or per 106 spleen cells zt:  the standard error corrected for the background response 
to the indicator erythrocytes. Data were analyzed statistically with the Student's t test.  The 
percent suppression  was determined as follows: 
mean PFC/106 for recipients of  normal and tolerant spleen cells~ 
% suppression =  1  mea"-"~  PFC/-"~106 for recipients o~ norma---i  splee---'~  cell'---s  ~  ,]  ×  100. 
Results 
Inability  of DHGG from  a  Healthy  Individual  to  Induce  Suppressor  Cells.  Although 
suppressor  T  cells  have  been  recently  demonstrated  in  HGG-tolerant  spleen  cell 
populations  (6-8),  universal  demonstration  of these  suppressor  cells  has  not  been 
reported (19-23). A majority of the successful attempts to generate suppression utilized 
HGG  purified  from  one  source  (RC)  of Cohn  fraction  II  (7-9,  14,  15,  20,  31). 
Suppressive activity of HGG-tolerant spleen cells was assayed by adoptive transfer of 
70  ×  106  viable spleen cells  from mice tolerized  10 days previously and  70  ×  106 
viable spleen  cells  from normal  animals  into  lethally  irradiated  (900  R)  syngeneic 
recipients (8, 9). 
Table I depicts the results obtained when the spleen cells from A/J mice tolerized 
with DHGG from either a healthy individual (Doy) or from the most commonly used 
source (RC) were assayed for the presence of suppressor cells. The injection of tolerant 
spleen cells from mice given 2.5  mg of DHGG (RC)  substantially suppressed  (61%) 
the PFC  response of normal spleen cells  (group 4), as previously reported  (8,  9).  In 
contrast,  2.5  mg  of  tolerogen  purified  by  DEAE  chromatography  of euglobulin- 
depleted  normal  plasma  (Doy)  did  not  generate  detectable  suppressor cell  activity 
against normal spleen cells (group 2).  The response in these recipients was increased 
to greater than  twice the response of normal controls  (group 3).  The DHGG (Doy) 
preparation  induced  considerable  unresponsiveness  as  demonstrated  by  adoptive 
transfer of tolerant spleen cells alone (group 1). Neither the suppression accomplished 
by RC-tolerant  spleen cells nor the increased response associated with Doy-tolerant 
spleen  cells can  be attributed  to  the  passive administration  of antigen-nonreactive 
spleen  cells,  since  recipients  injected  with  70  ×  106  viable and  70  ×  106  lethally 
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TAnLE  I 
Lack of Suppression after Tolerization with HGG from Euglobulin-Depleted Normal Plasma 
Group 
Spleen cells transferred* 
Tolerant 
DHGG  DHGG 
(Doy)  (Re) 
Normal 
PFC/106  Percent sup- 
Immunogen:~ 
HGG (RC)§  pressi°n[I 
1  70 ×  106  --  --  A-AHGG (Doy)  56 2:22  -- 
2  70 X  106  --  70 ×  106  A-AHGG (Doy)  847  2:198  0 
3  --  --  70 ×  106  A-AHGG (Doy)  356 2:64  -- 
4  --  70 ×  106  70 ×  106  A-AHGG (Doy)  138 2:77  61 
5  --  --  70 ×  106  A-AHGG (Doy)  343  2:60  -- 
+ 
70 ×  106 
(irradiated) 
* 900 R irradiated recipients were reconstituted with either normal spleen cells or spleen cells from tolerant 
mice that had received 2.5 mg of DHGG 10 days earlier or both. 
:~ Reconstituted  mice received 400/~g of AHGG on the day of cell transfer and again  10 days later. 
§ The mean  +  SE of the number of indirect PFC to HGG from 5-8 mice assayed 5 days after secondary 
challenge. 
[[ See Materials and Methods. 
to  those of recipients reconstituted with  70  ×  l0  s  viable normal  spleen cells alone 
(group 3). 
Lack of Suppression at Various Times after Tolerization.  Although suppressor cells could 
not be demonstrated in DHGG  (Doy)-tolerized spleen ce|ls 10 days after tolerization, 
the  possibilities that  suppressor cell activity had  arisen  later or waned  sooner were 
investigated. Table II illustrates investigations of splenic suppressor cell activity 3,  10, 
and 17 days after tolerization with DHGG from a normal individual (Doy). Suppressor 
cell activity was not detected at any of the times assayed post tolerization (groups 2, 
3,  and  4).  Furthermore,  as  in  the  previous  table,  the  addition  of  tolerant,  but 
nonsuppressive, DHGG  (Doy)-treated spleen cells to normal spleen cells increased the 
number of PFC to HGG in the recipients. 
Lack of Suppression with Tolerogen Purified from Individual Plasma.  Investigations were 
undertaken to determine whether the lack of induction of suppressor cells by DHGG 
purified  from  euglobulin-depleted  normal  plasma  (Doy)  was  associated  with  the 
original source of plasma or with the method of purification of the HGG. An aliquot 
of  normal  plasma  (Doy)  was  precipitated  with  20%  ethanol  and  lyophilized  to 
approximate  two  of the  major  procedures  to  which  the  pooled,  outdated  human 
plasma is subjected during Cohn  fractionation of the suppressive (RC)  preparation. 
In addition, DHGG  was purified from a  human myeloma protein (see Materials and 
Methods)  to assess the ability of HGG  of a  single subclass to induce  tolerance and 
suppressor cell activity. This IgG1 myeloma protein (Fit) is of particular interest since 
it  has  previously  been  shown  to  be  refractory  to  spontaneous  aggregation  (27). 
Deaggregated HGG from either the ethanol-precipitated normal plasma (Doy) or the 
myeloma protein  (Fit)  failed to induce  demonstrable suppressor cells (Fig.  1)  when 
assayed  10  days  after  tolerization,  at  the  peak  of  suppressor  T-cell  activity  (8). 
However, both preparations established unresponsiveness in the spleen cells of treated 
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TABLE II 
Lack of Suppression at Various Times after Tolerization with HGG  from Euglobulin-Depleted Normal 
Plasma 
Spleen cells transferred* 
Group  Tolerant  PFC/l0  s  Percent suppres- 
sion 
Normal  HGG (RC)~ 
3 Days  l0 Days  17 Days 
1  --  --  70  ×  106  --  38  +  22  -- 
2  70 x  106  --  --  70 x  106  508  3= 84  0 
3  --  70 X  10  6  --  70 X  10  6  1,928 3= 332  0 
4  --  --  70 X  106  70 x  106  190  "4- 28  0 
5  --  --  --  70  X  106  189 3=  100  -- 
* 900 R irradiated recipients were reconstituted with either normal spleen cells or spleen cells from tolerant 
mice that had received 2.5 mg of DHGG (Doy) 3,  10, or 17 days earlier or both.  Reconstituted  mice 
received 400 #g ofA-AHGG (RC) on the day of cell transfer and again l0 days later. 
:[: See Table I, footnote §. 
with  either  nonsuppressive  preparation  of  DHGG  (Doy  or  Fit)  responded  with 
substantially greater PFC than recipients of normal spleen cells alone, as previously 
observed in Tables I and II. Therefore, unresponsiveness to HGG can be established 
in the absence of demonstrable suppressor cells by the injection of DHGG  purified 
from the plasma of either a  healthy donor or a  myeloma patient. 
Generation  of  Suppression  by  Several  Commercially  Acquired  Cohn  Fraction  II 
Preparations.  Although pooled, outdated human plasma varies in many respects from 
an individual sample of human plasma, the commercial Cohn fractionation procedure 
may be responsible for the generation of the suppressive effects associated with  the 
RC preparation. Cohn fraction II obtained from three additional commercial sources 
(Materials and  Methods)  was  used  to  investigate the ability of various commercial 
samples of HGG  to induce suppressor cell activity. In these experiments, irradiated 
recipients received either spleen cells from mice tolerized with DHGG  prepared from 
the  Cohn  fraction  II  from  the  commercial  source  under  investigation,  or  normal 
spleen cells, or both normal and tolerant cells. These recipients were compared with 
the  recipients  of spleen  cells  from  mice  tolerized  with  DHGG  prepared  from  the 
conventional (RC) source. 
The  induction  of suppressor cell activity in  the spleens of mice treated  with  one 
commercial  HGG  preparation  (US)  is  presented  in  Table  III.  In  the  two  separate 
experiments presented, DHGG  purified from the commercial HGG preparation (US) 
generated considerably less suppressor cell activity (group 2) than did the conventional 
(RC)  source  (group  5).  This  was  true  regardless of the  magnitude  of the  normal 
response  in  these  recipients  or  the  degree  of  suppression  stimulated  by  the  RC 
preparation. Additionally, these results were unchanged  irrespective of the source of 
HGG with which the recipients were challenged or against which they were plaqued. 
Thus,  there was serologic identity between these two HGG preparations at the levels 
of both antigenic challenge and antibody production. For this reason, recipients were 
challenged with and  PFC were detected against the conventional (RC)  preparation 
of HGG in several experiments. 
Similar results were  obtained  in  a  series of experiments  undertaken  to assess the 
ability of DHGG  purified from each of the four sources of commercially fractionated 630  HUMAN  GAMMA  GLOBULIN  TOLERANCE  LACKING  SUPPRESSOR  CELLS 
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Fro.  1.  Lack of suppression with  DHGG  purified from individual  plasma. The  percent  of unre- 
sponsiveness or suppression was calculated for individual recipients of 70 ×  106 tolerant (Tol) spleen 
cells alone or  70  ×  106 tolerant  and  70  ×  10  n normal spleen cells.  Donors were tolerized  10 days 
before transfer with DHGG  purified from Cohn fraction II  (RC), ethanol-precipitated plasma from 
a  healthy  individual  (Doy),  or  plasma  from  a  myeloma  patient  (Fit).  The  mean  ±  SE  of 5-9 
recipients is presented. 
TABLE III 
Suppression after Tolerization with HGG  frorn Commercial (US) Cohn Fraction H 
Spleen cells transferred* 
Group  Tolerant  Immunogen:~ 
DHGG  DHGG 
(US)  (RC) 
Normal 
PFC/106 to HGG  sources§ 
Percent 
suppres- 
sion1 
(US)  (RC)  (US)  (RC) 
1  70  ×  l0  6  --  --  A-AHGG  (US)  18  +  13  11  ±  8  --  -- 
2  70  x  10 6  --  70  ×  10  s  A-AHGG  (US)  172  ±  46  163  +  50  8  0 
3  --  --  70  ×  106  A-AHGG  (US)  186  ±  46  161  +  42  -- 
4  --  70  x  106  --  A-AHGG  (RC)  <1  <1  --  -- 
5  --  70  ×  106  70  ×  106  A-AHGG  (RC)  201  +  73  173  +  59  59  58 
6  --  --  70  ×  106  A-AHGG  (RC)  495  +  78  416  __.  76  --  -- 
1  70  ×  106  --  --  A-AHGG(US)  19  ±  5  15  +  4  --  -- 
2  70  ×  106  --  70  ×  l06  A-AHGG  (US)  587  ±  99  523  ±  94  28  22 
3  --  --  70  ×  10  ~  A-AHGG  (US)  810  ±  128  669  ±  117  --  -- 
4  --  70  x  106  --  A-AHGG  (US)  1  ±  1  <l  --  -- 
5  --  70  ×  106  70  x  l0  n  A-AHGG  (US)  166  ±  23  135  ±  14  80  80 
* See Table I, footnote * 
Reconstituted mice received 400/tg of AHGG  on the day of cell transfer and  again  10 days later. The 
mean  ±  SE  of the  number  of indirect  PFC  from 5-8  mice per  group plaqued  5  days after secondary 
challenge is presented. 
§  Recipients were plaqued separately to HGG  from either source. 
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Fxc.  2.  Suppression and tolerance induced with DHGG from commercial Cohn fraction II. The 
percent of unresponsiveness or suppression was calculated for individual recipients of tolerant (Tol) 
spleen cells alone or tolerant and normal spleen cells (see Fig. 1). Donors were tolerized with DHGG 
purified from each of four sources (RC, S, M, or US). Recipients were separately challenged with 
and plaqued to the HGG source under investigation (S, M, or US) or the conventional source (RC). 
The mean ±  SE of two experiments with each source is presented. 
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plasma  to  induce  suppression  (Fig.  2).  Although  all  preparations  were  capable  of 
stimulating  suppressor cells,  the  level of suppression  generated  by each preparation 
varied  greatly.  Nevertheless,  DHGG  purified  from  all  sources  established  a  solid 
unresponsive state which was stable upon adoptive transfer  10 days after tolerization. 
Duration of Tolerance Established by  Various HGG Preparations.  The data in Table III 
and  Fig.  2  suggest  that  the  commercially  acquired  HGG  preparations  which  were 
Cohn-fractionated from outdated, pooled human plasma were capable of stimulating 
suppressor cells  to HGG, albeit  with  varying efficiencies.  On the other hand,  HGG 
purified from either the plasma of a single healthy donor (Doy) or a myeloma patient 
(Fit)  was incapable of generating detectable  suppressor cell activity.  If suppressor T 
cells  are  responsible  for the  induction  and  maintenance  of immunologic  unrespon- 
siveness,  then  the  duration  of unresponsiveness  in  the  T  and  B  lymphocytes  in 
tolerized mice would be expected to reflect the level of suppressor cell activity in those 
mice. Therefore, mice were injected with 2.5 mg of DHGG from these various sources 
and assessed  for the degree of immunocompetence of either  the whole spleen  or the 
splenic B cells at various times after treatment. 
To assess the responsiveness  of the total spleen  cells,  mice were injected  twice,  10 
days apart, and plaqued 4 days after the secondary challenge. As illustrated  in Table 
IV,  the  conventional  DHGG  preparation  (RC)  induced  a  solid  unresponsive  state 
lasting  at  least  20  wk  and  reflecting  a  lack  of responsive  T  cells  as  previously 
documented (22, 32). Similarly, DHGG from one of the commercial sources (US) and 
from a  healthy donor (Doy) established  unresponsive states  in treated  mice of up to 
12  and  19  wk,  respectively.  However,  mice  treated  with  DHGG  from  the  two 
remaining commercial sources (M and S) possessed responsive spleen cells as early as 
3 wk after treatment.  It can be assumed that the responsive spleen cells in the latter 632  HUMAN GAMMA GLOBULIN TOLERANCE  LACKING SUPPRESSOR  CELLS 
TAnLE  IV 
Duration of Tolerance after Injection of Various DHGG Preparations 
Days post  Source of to-  Antigenic chal- 
tolerization  lerogen*  lenge~: 
PFC/10  6 to HGG sources§ 
(RC)  (M)  (S)  (US) 
--  --  A-AHGG (RC)  743 +  350 
72  (RC)  A-AHGG (RC)  1 ~  1 
147  (RC)  A-AHGG (RC)  8 zl: 3 
63  (Doy)  A-AHGG (RC)  4 -+ 2 
137  (Doy)  A-AHGG (RC)  15 +  9 
21  (M)  A-AHGG (M)  126 +  86 
21  (S)  A-AHGG (S)  82:1:64 
60  (S)  A-AHGG (S)  201  :t: 44 
27  (US)  A-AHGG (US)  16 +  5 
88  (US)  A-AHGG (US)  1l  :t: 2 
863  :1: 430  786 ±  409  658  ±  312 
2±1  2+1  2+1 
55 ±  39 
57  ±  42 
210 ±  51 
11+7 
6±2 
* 2.5 mg of DHGG was injected i.p. 
:~ 400/tg of AHGG was injected i.v. at various times after the injection of DHGG as indicated. The mice 
were given a secondary challenge of 400/tg of AHGG i.p.  10 days later, and individual  spleens were 
plaqued 4 days after the secondary challenge. 
§ The mean  :1: SE of the number of indirect PFC to HGG from 4-6 mice plaqued separately to HGG from 
each source. 
two groups reflect the presence of responsive T,  as well as B, lymphocytes since the 
response to HGG is T-dependent. 
To assess the responsiveness of splenic B cells in tolerized mice, advantage was made 
of the observation that  the  injection of LPS  with  antigen  into  HGG-tolerant  mice 
stimulates any HGG-responsive splenic B cells present into PFC, even in the presence 
of unresponsive T  lymphocytes (33).  Using this protocol, it has  been  demonstrated 
that HGG-responsive splenic B  cells reappear as early as 45 days after the induction 
of unresponsiveness established by DHGG  (RC) and slowly repopulate the spleen (34, 
35). Therefore, mice treated with DHGG  from various sources were challenged with 
400/xg of AHGG  followed 3 h  later with 50 ~g of LPS and plaqued 6  days after this 
challenge. 
Table V  summarizes the results of experiments investigating:  (a)  the duration of 
unresponsiveness in splenic B cells as assessed by challenge with antigen and LPS; (b) 
the  duration  of unresponsiveness  in  splenic T  cells  as  assessed  by  challenge  with 
antigen  alone  (Table  IV);  and  (c)  the  level  of suppression  generated  by  various 
DHGG  preparations  (Table III and Fig. 2).  Of the three strongly tolerogenic HGG 
preparations  (RC,  Doy,  and  US),  the  capacity to  generate suppressor cells encom- 
passed  both  extremes.  RC  stimulated  the  strongest  suppressor  cell  activity,  US 
stimulated the weakest, and Doy stimulated no detectable suppression. On the other 
hand, of the three most strongly suppressive HGG preparations (RC, S, and M), RC 
induced a  solid unresponsive state in both the T  and B  lymphocytes, whereas neither 
S  nor  M  maintained  unresponsiveness  far  beyond  that  demonstrated  by  adoptive 
transfer at 10 days post tolerization (Fig. 2). Thus, the degree of suppression generated 
by  the  various  HGG  preparations  does  not  correlate  with  the  ability  of  these 
preparations  to  induce  and  maintain  unresponsiveness  in  either  splenic  T  or  B 
lymphocytes. These  data suggest  that  suppressor T  cells are not  responsible for the 
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TABLE V 
Lack of Correlation between  Establishment of Tolerance and Generation of Suppressor 
Cells to HGG 
633 
Source of tolero-  Percent suppres- 
gen*  sion:]: 
Earliest response in: 
B cells§,  T cellsl[ 
days post tolerogen 
RC  53-91  59  > 147 
S  33-54  21  21 
M  31-47  21  21 
US  0-28  27  >88 
Doy  0  56  > 137 
* See Table IV, footnote * 
:[: Range of percent suppression from nine experiments calculated as described in 
Materials and Methods. 
§ 400 p.g of AHGG was injected i.v. at various times after the injection of DHGG as 
indicated. 50 lag of LPS was injected i.v. 3 h after antigenic  challenge, and individual 
spleens were plaqued 6 days later. 
[I See Table IV, footnote  :[. 
Discussion 
The generation of suppressor cell activity in the spleens of HGG-tolerant mice is 
variable and dependent upon the source of the HGG utilized. The unresponsive state 
established  by DHGG purified  from  each  of the  sources assessed  was  stable  upon 
adoptive transfer into irradiated recipients. All four of the samples of Cohn-fraction- 
ated,  pooled  human  plasma  obtained  commercially stimulated  suppressor  cells  as 
assayed by the transfer of tolerant spleen cells and normal spleen cells into irradiated 
recipients.  This  suppression  ranged  from  0  to  54%  with  three  of the  commercial 
preparations  (M,  S,  and  US),  whereas  the  preparation  (RC)  most  widely used  in 
previously published  studies  of HGG-specific suppressor  cells  (7-9,  14,  15,  20,  31) 
induced 53-91% suppression. On the other hand, samples prepared from individual 
donors,  a  myeloma patient  and  a  healthy  donor,  did  not  generate  demonstrable 
suppressor cell activity to HGG. These findings suggest that suppressor cells  are not 
required for the induction or maintenance of tolerance to HGG, since tolerance was 
induced by each of the preparations.  Conversely, the generation of suppressor cells 
does not  appear to be a  mandatory result  of the  establishment  of an  unresponsive 
state to HGG in adult mice. The concept that suppressor T  cells  are only incidental 
to the tolerant state is supported by previous observations in mice devoid of thymus- 
dependent lymphocytes. Congenitally athymic, nude mice can be rendered unrespon- 
sive to HGG by the injection of either aggregated HGG (36)  or deaggregated HGG 
(28),  as can adult  thymectomized, irradiated,  and bone marrow-reconstituted mice 
(23). 
Additionally, evidence of the establishment of tolerance to HGG in the absence of 
suppressor T  cells in adult mice bearing competent T  lymphocytes has been provided 
using adoptive transfer (22,  23), parabiosis (21),  and low-dose tolerization  (20).  The 
conditions under  which  HGG-specific suppressor cells  can  be  demonstrated  in  the 
spleens of tolerant mice appear to be restricted.  Suppressor cells  are only transiently 
associated with the tolerant state to HGG (6, 8,  18), and they cannot be reinduced 634  HUMAN  GAMMA GLOBULIN TOLERANCE LACKING SUPPRESSOR CELLS 
with a second injection of tolerogen once they have been exhausted (20), despite the 
persistence to T-cell tolerance. Finally, suppressor cells cannot be detected in neonates 
tolerized  to  HGG  through  the  colostral  transmission  of tolerogen  (19).  Although 
suppressor T cells may regulate immune responsiveness, an obligate role for these cells 
in the establishment of tolerance to HGG appears doubtful in light of these numerous 
examples of tolerance without suppression. The converse situation in which suppressor 
cells  exist  without  tolerance is  documented  by  the  presence of suppressor  cells  in 
HGG-primed mice (18).  In parallel to the data presented here, recent observations 
(37) suggest that suppressor cells are coincidental to, but not obligate for, tolerance to 
another soluble protein antigen human serum albumin in which suppressor T  cells 
have been well documented (38). 
The mechanism by which DHGG purified from certain preparations of HGG elicits 
suppressor cells whereas tolerogen from other preparations does not  is unclear. The 
suppressive activity of the commercially acquired preparations may reflect their origin 
as  outdated,  pooled plasma  or their handling,  storage,  or method  of purification. 
Although  the  size  of the  various  human  plasma  pools  used  in  the  commercial 
fractionation is  unknown,  their heterogeneity may account for the ability of these 
preparations to generate suppression. Variability in pool size and heterogeneity may 
be responsible for the varying efficiencies of suppressor cell induction among com- 
mercial sources. On the other hand,  the observation that ethanol precipitation and 
lyophilization of a nonsuppressive preparation did not generate a suppressive prepa- 
ration  does  not  exclude the  possibility  that  the  HGG  is  altered  during  the  more 
extensive commercial fractionation. A particular subclass of Ig or a denatured product 
of I-IGG present in small and varied quantity in the commercial preparations may be 
responsible  for  the  varying  levels  of suppressor  cell  activity  generated  by  these 
preparations. This concept would be consistent with the observation that suppressor 
cells are not stimulated in mice tolerized with a  low dose of commercial HGG (18). 
There  may  be  too  little  suppressive  reagent  at  this  dose  of  HGG  to  generate 
suppression. Further support for this concept comes from observations that fragments 
of fl-galactosidase will activate T  cells capable of suppressing the immune response to 
the whole protein (39).  Experiments designed to investigate the active component(s) 
in the suppressive HGG preparations are in progress. 
The level of suppressor cells to HGG detected in the present studies appears to be 
unrelated to: (a) the establishment of tolerance as assessed by the adoptive transfer of 
tolerized spleen cells into irradiated recipients; (b) the duration of tolerance in the B 
cells of these tolerized mice; or (c) the duration of tolerance in the T  cells as reflected 
by the response of the total spleen at a time when splenic B cells are responsive. If the 
maintenance of tolerance were due to suppressor cells, then the level of unresponsive- 
ness would be expected to parallel the degree and duration of suppression. This was 
not  the  case,  underscoring  the  observation  that  no  causal  relationship  between 
suppressor cells and tolerance could be detected to this soluble protein antigen HGG. 
Furthermore, the lack of suppressor cells in  neonatally-induced tolerance to  HGG 
(19)  and  the  inability  to  induce  new  suppressors  in  unresponsive  mice  after  the 
disappearance of the initial,  transient  suppressor cells  (20)  speak against  a  role for 
suppressor T  cells in states of unresponsiveness to many self-antigens. The antigens 
contained in this catagory would be those that  are present  at  birth and  remain  in 
contact with the immune system in tolerogenic concentrations throughout the life of 
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Along with other models of tolerance devoid of or independent  from suppressor 
cells, the model presented here suggests that the maintenance of tolerance to HGG in 
the B  lymphocytes may be accomplished through  an  intrinsic unresponsiveness of 
these cells. The mechanisms  responsible for the establishment  and  maintenance of 
unresponsiveness in B cells have been divided into two broad categories (40). During 
extrinsic (or peripheral)  inhibition, competent B  cells are present  but  inhibited by 
mechanisms that are independent of the B cells and that require perpetuation. These 
mechanisms may involve antibody, antigen-antibody complexes, suppressor cells, and 
soluble mediators. On the other hand, the mechanisms responsible for intrinsic  (or 
central) unresponsiveness directly affect the B cells, resulting in the irreversible loss of 
competent B  lymphocytes, and  they do not  require further external influences for 
their maintenance. The direct effect of antigen to clonally delete or abort B cells is 
possibly the clearest example of an intrinsic mechanism. 
The concept of receptor blockade, advanced by MSller et al.  (41), suggested that 
tolerant B cells are not irreversibly inactivated by antigen but rather are reversibly 
inhibited by the blockade of signal recognition at the antigen receptors on the cells. 
More  recently, Fernandez  and  M611er  (42)  have  reported  that  cells  bearing  both 
antigen  receptors  and  receptors  for  a  polyclonal  B-cell  activator  are  irreversibly 
inactivated when exposed to tolerogenic levels of both moieties at once. An extrapo- 
lation  of this  model  to  T-dependent  antigens  would  postulate  that  cells  bearing 
receptors for both antigen and T-cell help (analogous to polyclonal B-cell activation) 
could also be irreversibly inactivated. Such a model of inactivation would vary from 
other models of intrinsic unresponsiveness involving c[onal deletion or abortion only 
in that helper T  cells would be required to accomplish irreversible B-cell unrespon- 
siveness. 
If neither reversible receptor blockade nor T-cell suppression are fundamental in 
unresponsiveness  to  a  T-dependent  soluble  protein  antigen  like  HGG,  then  the 
tolerant state established to HGG may be a  model for intrinsic unresponsiveness in 
which B lymphocytes are irreversibly inactivated. The only other extrinsic mechanism 
of note bearing on this unresponsive state is the network theory of anti-idiotypes (43), 
which has not been extensively investigated with soluble protein antigens to date. 
Summary 
A  model of unresponsiveness to human ),-globulin (HGG) which is maintained in 
the  absence  of demonstrable  suppressor  cells  has  been  described.  A/J  mice  were 
tolerized with deaggregated HGG purified from a variety of sources. The spleen cells 
from these tolerized mice were assessed for their ability to suppress the response of 
normal spleen cells to HGG when transferred into lethally irradiated mice. All of the 
HGG preparations obtained from commercial sources as Cohn fraction II of pooled, 
outdated plasma induced suppressor cells to HGG, although not of equal magnitude. 
However, suppressor cells could not be demonstrated in the spleens of mice tolerized 
with  deaggregated  HGG  purified  from  the  plasma  of a  healthy  individual.  This 
inability to detect suppression was independent of the method of purification of the 
HGG and of the time of assessment of the putative suppressor cells after tolerization. 
Similarly,  deaggregated  HGG  isolated  from  an  IgG1  )~-myeloma protein  induced 
unresponsiveness to HGG but did not stimulate demonstrable suppressor cells. These 
data suggest that suppressor T  cells are not involved in the maintenance of tolerance 
to this antigen, although they may play a regulatory role in the immune response to 636  HUMAN GAMMA GLOBULIN TOLERANCE LACKING SUPPRESSOR  CELLS 
HGG. Support  for this concept was obtained  by assessing the duration of unrespon- 
siveness  in  the  T  and  B  lymphocytes  of mice  tolerized  with  the  various  HGG 
preparations.  Mice tolerized with the HGG preparations  that stimulated  little or no 
suppression  were  among  the  last  to  recover  responsiveness.  Indeed,  there  was  no 
consistent  correlation  between  the level of suppressor cell  activity and the degree of 
unresponsiveness  in either  the splenic  T  or B  lymphocytes. Thus,  although  certain 
HGG preparations may provide a tool for the generation of antigen-specific suppressor 
T  cells, the utilization of these suppressive preparations may be inappropriate for the 
investigation of the mechanisms of the induction and maintenance of the unresponsive 
state. 
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